Exact Mass: 502.2414
Exact Mass Matches: 502.2414
Found 267 metabolites which its exact mass value is equals to given mass value 502.2414
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Eriojaposide A
Eriojaposide A is found in fruits. Eriojaposide A is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). Eriojaposide A is found in fruits. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Amcinonide
Amcinonide is only found in individuals that have used or taken this drug. It is a corticosteroid.The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Amcinonide has affinity for the glucocorticoid receptor. It has weak affinity for the progesterone receptor, and virtually no affinity for the mineralocorticoid, estrogen, or androgen receptors. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
3-Oxo-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
3-Oxo-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 3-Oxo-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). 3-Oxo-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
4-[(E)-3-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one
(6R,7E,9R)-9-hydroxy-4,7-megastigmadien-3-one 9-O-[alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside]|ficumegasoside
4-O-alpha-L-arabinofuranosyl-(1-6)-beta-D-glucopyranoside of (4S)-4-hydroxy-beta-ionone
2alpha,4alpha,7beta,9alpha,10beta,13alpha,15-heptahydroxy-5alpha,20-diacetoxy-11(15->1)abeotaxa-11-ene|taxuyunnamine T
Cortistatin D
A member of the class of cortistatins that is cortistatin C in which the hydrogen at position 17 has been replaced by a hydroxy group.
Ile Gln Asn Glu
Amcinonide
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid CONFIDENCE standard compound; INTERNAL_ID 2825
4-[(E)-3-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one
4-[(E)-3-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one_major
Ala Glu Gln Arg
Ala Glu Arg Gln
Ala Gln Glu Arg
Ala Gln Arg Glu
Ala Arg Glu Gln
Ala Arg Gln Glu
Cys Pro Gln Arg
Cys Pro Arg Gln
Cys Gln Pro Arg
Cys Gln Arg Pro
Cys Arg Pro Gln
Cys Arg Gln Pro
Asp Ile Gln Gln
Asp Leu Gln Gln
Asp Asn Arg Val
Asp Asn Val Arg
Asp Gln Ile Gln
Asp Gln Leu Gln
Asp Gln Gln Ile
Asp Gln Gln Leu
Asp Arg Asn Val
Asp Arg Val Asn
Asp Val Asn Arg
Asp Val Arg Asn
Glu Ala Gln Arg
Glu Ala Arg Gln
Glu Ile Asn Gln
Glu Ile Gln Asn
Glu Leu Asn Gln
Glu Leu Gln Asn
Glu Asn Ile Gln
Glu Asn Leu Gln
Glu Asn Gln Ile
Glu Asn Gln Leu
Glu Gln Ala Arg
Glu Gln Ile Asn
Glu Gln Leu Asn
Glu Gln Asn Ile
Glu Gln Asn Leu
Glu Gln Gln Val
Glu Gln Arg Ala
Glu Gln Val Gln
Glu Arg Ala Gln
Glu Arg Gln Ala
Glu Val Gln Gln
Ile Asp Gln Gln
Ile Glu Asn Gln
Ile Glu Gln Asn
Ile Asn Glu Gln
Ile Asn Gln Glu
Ile Gln Asp Gln
Ile Gln Glu Asn
Ile Gln Gln Asp
Lys Asn Asn Gln
Lys Asn Gln Asn
Lys Gln Asn Asn
Leu Asp Gln Gln
Leu Glu Asn Gln
Leu Glu Gln Asn
Leu Asn Glu Gln
Leu Asn Gln Glu
Leu Gln Asp Gln
Leu Gln Glu Asn
Leu Gln Asn Glu
Leu Gln Gln Asp
Asn Asp Arg Val
Asn Asp Val Arg
Asn Glu Ile Gln
Asn Glu Leu Gln
Asn Glu Gln Ile
Asn Glu Gln Leu
Asn Ile Glu Gln
Asn Ile Gln Glu
Asn Lys Asn Gln
Asn Lys Gln Asn
Asn Leu Glu Gln
Asn Leu Gln Glu
Asn Asn Lys Gln
Asn Asn Gln Lys
Asn Gln Glu Ile
Asn Gln Glu Leu
Asn Gln Ile Glu
Asn Gln Lys Asn
Asn Gln Leu Glu
Asn Gln Asn Lys
Asn Arg Asp Val
Asn Arg Val Asp
Asn Val Asp Arg
Asn Val Arg Asp
Pro Cys Gln Arg
Pro Cys Arg Gln
Pro Gln Cys Arg
Pro Gln Arg Cys
Pro Arg Cys Gln
Pro Arg Gln Cys
Gln Ala Glu Arg
Gln Ala Arg Glu
Gln Cys Pro Arg
Gln Cys Arg Pro
Gln Asp Ile Gln
Gln Asp Leu Gln
Gln Asp Gln Ile
Gln Asp Gln Leu
Gln Glu Ala Arg
Gln Glu Ile Asn
Gln Glu Leu Asn
Gln Glu Asn Ile
Gln Glu Asn Leu
Gln Glu Gln Val
Gln Glu Arg Ala
Gln Glu Val Gln
Gln Ile Asp Gln
Gln Ile Glu Asn
Gln Ile Asn Glu
Gln Ile Gln Asp
Gln Lys Asn Asn
Gln Leu Asp Gln
Gln Leu Glu Asn
Gln Leu Asn Glu
Gln Leu Gln Asp
Gln Asn Glu Ile
Gln Asn Glu Leu
Gln Asn Ile Glu
Gln Asn Lys Asn
Gln Asn Leu Glu
Gln Asn Asn Lys
Gln Pro Cys Arg
Gln Pro Arg Cys
Gln Gln Asp Ile
Gln Gln Asp Leu
Gln Gln Glu Val
Gln Gln Ile Asp
Gln Gln Leu Asp
Gln Gln Val Glu
Gln Arg Ala Glu
Gln Arg Cys Pro
Gln Arg Glu Ala
Gln Arg Pro Cys
Gln Val Glu Gln
Gln Val Gln Glu
Arg Ala Glu Gln
Arg Ala Gln Glu
Arg Cys Pro Gln
Arg Cys Gln Pro
Arg Asp Asn Val
Arg Asp Val Asn
Arg Glu Ala Gln
Arg Glu Gln Ala
Arg Asn Asp Val
Arg Asn Val Asp
Arg Pro Cys Gln
Arg Pro Gln Cys
Arg Gln Ala Glu
Arg Gln Cys Pro
Arg Gln Glu Ala
Arg Gln Pro Cys
Arg Val Asp Asn
Arg Val Asn Asp
Val Asp Asn Arg
Val Asp Arg Asn
Val Glu Gln Gln
Val Asn Asp Arg
Val Asn Arg Asp
Val Gln Glu Gln
Val Gln Gln Glu
Val Arg Asp Asn
Val Arg Asn Asp
Eriojaposide A
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
3-Oxo-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
[(2R,3R,4S,5R,6R)-5-(3,6-diaminohexanoylamino)-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate
(2R,3S)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8R)-8-methoxy-5-(2-methoxyacetyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
(2S,3R)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-[(2S,3R)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]benzonitrile
phenyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
phenyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
phenyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
phenyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2S,3R)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(3-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-[(2R,3S)-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]benzonitrile
N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
phenyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
phenyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
phenyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(17R,19E)-19,20-Didehydroajmalan-17-ol 3,4,5-trimethoxybenzoate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
4,4-Bis(para-(trimethylsilyl)oxy-phenyl)-valeric acid trimethylsilyl ester
Streptothricin F
A streptothricin in which the peptide side-chain consists of a single unit of beta-lysine.
(4R)-3,5,5-trimethyl-4-[(E,3R)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybut-1-enyl]cyclohex-2-en-1-one
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
streptothricin
An N-glycosyl compound consisting of 2-amino-4-O-carbamoyl-2-deoxy-N-[(3aS,7R,7aS)-7-hydroxy-4-oxooctahydro-2H-imidazo[4,5-c]pyridin-2-ylidene]-beta-D-gulopyranosylamine in which the amino group at position 2 of the gulopyranosyl moiety is acylated by a peptide unit made up of between 1 and 7 N(epsilon)-linked units of beta-lysine.
(4r)-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}but-1-en-1-yl]-3,5,5-trimethylcyclohex-2-en-1-one
2,4,4-trimethyl-3-{3-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]but-1-en-1-yl}cyclohex-2-en-1-one
(3s)-n-[(2r,3r,4s,5r,6r)-2-{[(3as,7r,7as)-4,7-dihydroxy-3h,3ah,6h,7h,7ah-imidazo[4,5-c]pyridin-2-yl]amino}-4,5-dihydroxy-6-[(c-hydroxycarbonimidoyloxy)methyl]oxan-3-yl]-3,6-diaminohexanimidic acid
4-{3-[(3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]but-1-en-1-yl}-3,5,5-trimethylcyclohex-2-en-1-one
methyl 2-[(1r,2s,8s,10s,12r,13s,14s,17s,19r,20s,21r,23z)-21-hydroxy-5,13,20-trimethyl-9-methylidene-4,22-dioxo-3-oxaoctacyclo[14.7.1.0²,⁶.0²,¹⁴.0⁸,¹³.0¹⁰,¹².0¹⁷,¹⁹.0²⁰,²⁴]tetracosa-5,16(24)-dien-23-ylidene]propanoate
2,4,4-trimethyl-3-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
4-(3-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}but-1-en-1-yl)-3,5,5-trimethylcyclohex-2-en-1-one
(4r)-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
methyl 2-{21-hydroxy-5,13,20-trimethyl-9-methylidene-4,22-dioxo-3-oxaoctacyclo[14.7.1.0²,⁶.0²,¹⁴.0⁸,¹³.0¹⁰,¹².0¹⁷,¹⁹.0²⁰,²⁴]tetracosa-5,16(24)-dien-23-ylidene}propanoate
5-hydroxy-8,8,10,10,12-pentamethyl-6-(2-methylpropyl)-2-phenyl-3,6-dihydro-2h-1,11-dioxatetracene-4,7,9-trione
(6R,7E,9R)-9-9-hydroxy-4,7-megastigmadien-3-one
{"Ingredient_id": "HBIN012777","Ingredient_name": "(6R,7E,9R)-9-9-hydroxy-4,7-megastigmadien-3-one","Alias": "NA","Ingredient_formula": "C24H38O11","Ingredient_Smile": "CC1=CC(=O)CC(C1C=CC(C)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42640","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}